Evidence map›Paper›PMID 7534404›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1995

Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase Htk.

B D Bennett, F C Zeigler, Q Gu, B Fendly, A D Goddard, N Gillett, W Matthews

Open access · greenAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Membrane-mediated regulation of vascular identity.Birth defects research. Part C, Embryo today : reviews · 2016
    Review
  7. Henipavirus receptor usage and tropism.Current topics in microbiology and immunology · 2012
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

B D BennettDepartment of Molecular Biology, Genentech, Inc., South San Francisco, CA 94080.
F C Zeigler
Q Gu
B Fendly
A D Goddard
N Gillett
W Matthews

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Htk is a receptor protein-tyrosine kinase that is related to the EPH subfamily of tyrosine kinases. The receptor has a wide tissue distribution including expression in several myeloid hematopoietic cell lines. Using an Htk-Fc fusion protein, a protein ligand for this receptor was expression cloned from the murine kidney mesangial cell line SV40MES 13. The Htk ligand cDNA encodes a transmembrane protein of 336 amino acids. Binding competition experiments demonstrated a Kd of 535 pM for binding of Htk-Fc to the Htk ligand. Incubation of 3T3 cells expressing Htk with COS-7 cells expressing the ligand resulted in tyrosine phosphorylation of Htk. The ligand, like its receptor, is widely expressed and may function in a variety of tissues. However, we localized hematopoietic expression of Htk to the monocytic lineage, suggesting that the ligand may play a role in differentiation and/or proliferation of these cells.

Indexed as

3T3 CellsAdultAmino Acid SequenceAnimalsBinding, CompetitiveBlotting, NorthernCell LineChlorocebus aethiopsCloning, MolecularEphrin-B2FemaleFetal BloodFetusGlomerular MesangiumHematopoietic Stem CellsHumansEphrin-B2LigandsMembrane ProteinsPhosphoproteinsPhosphotyrosineReceptor, EphB4Receptor Protein-Tyrosine KinasesRecombinant Fusion ProteinsTyrosine

Identifiers

PMID7534404
PMCPMC42383
OpenAlexW2085397699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.